EKF Diagnostics (LON:EKF) Shares Pass Below 200 Day Moving Average – Here’s Why

EKF Diagnostics Holdings plc (LON:EKF) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 25.66 and traded as low as GBX 25.20. EKF Diagnostics shares last traded at GBX 26, with a volume of 46,083 shares changing hands.

Wall Street Analyst Weigh In

Separately, Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 35 target price on shares of EKF Diagnostics in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, EKF Diagnostics currently has an average rating of “Buy” and an average target price of GBX 35.

EKF Diagnostics Price Performance

The firm has a market cap of £111.87 million, a PE ratio of 55.32 and a beta of 0.51. The business’s 50-day simple moving average is GBX 26.19 and its 200 day simple moving average is GBX 25.66. The company has a current ratio of 4.16, a quick ratio of 1.77 and a debt-to-equity ratio of 2.01.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.